Track topics on Twitter Track topics that are important to you
Ceapro (TSXV:CZO) a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial results and operational highlights for the quarter ended September 30, 2018. As quoted in the press release: “Over the course of 2018 we have made significant progress in transitioning our business model towards the … Continued
The post Ceapro Reports 2018 Third Quarter and Nine-Month Financial Results and Operational Highlights appeared first on Investing News Network.NEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...